HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Yamashita Selected Research

Antigens

4/2002Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients.
8/2001The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.
6/2000Induction of cytotoxic T lymphocytes from peripheral blood of human histocompatibility antigen (HLA)-A31(+) gastric cancer patients by in vitro stimulation with antigenic peptide of signet ring cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Yamashita Research Topics

Disease

32Neoplasms (Cancer)
01/2021 - 01/2000
12Neoplasm Metastasis (Metastasis)
01/2021 - 08/2000
11Breast Neoplasms (Breast Cancer)
01/2022 - 01/2000
9Pain (Aches)
05/2016 - 11/2000
9Amyloidosis
01/2008 - 02/2000
8Polyneuropathies (Polyneuropathy)
06/2011 - 02/2000
8Thrombosis (Thrombus)
05/2006 - 03/2000
7Inflammation (Inflammations)
04/2019 - 03/2000
6Type 2 Diabetes Mellitus (MODY)
10/2017 - 01/2000
6Infections
04/2016 - 05/2000
5Systemic Scleroderma (Systemic Sclerosis)
04/2019 - 02/2016
5Fibrosis (Cirrhosis)
02/2018 - 07/2000
5Head and Neck Neoplasms (Head and Neck Cancer)
11/2017 - 08/2000
5Squamous Cell Carcinoma of Head and Neck
04/2015 - 08/2000
5Necrosis
02/2011 - 04/2000
4Stroke (Strokes)
01/2014 - 05/2003
4Lymphoma (Lymphomas)
06/2013 - 06/2000
4Pathologic Constriction (Stenosis)
06/2011 - 04/2000
4Stomach Neoplasms (Stomach Cancer)
04/2006 - 06/2000
4Habitual Abortion (Recurrent Miscarriage)
11/2001 - 02/2000
3Hyperglycemia
01/2020 - 01/2001
3Interstitial Lung Diseases (Interstitial Lung Disease)
02/2018 - 02/2016
3Body Weight (Weight, Body)
11/2017 - 05/2001
3Dementia (Dementias)
01/2017 - 05/2003
3Radiculopathy (Radiculopathy, Cervical)
05/2016 - 05/2003
3Hematologic Neoplasms (Hematological Malignancy)
04/2016 - 02/2000
3Hypoxia (Hypoxemia)
02/2015 - 02/2001
3Insulin Resistance
02/2015 - 01/2001
3Colorectal Neoplasms (Colorectal Cancer)
03/2012 - 09/2001
3Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
02/2012 - 06/2011
3Atherosclerosis
03/2010 - 01/2001
3Osteosarcoma (Osteogenic Sarcoma)
06/2009 - 03/2002
3Amyloid Plaque
01/2008 - 04/2000
3Hypersensitivity (Allergy)
12/2007 - 07/2001
3Congenital Abnormalities (Deformity)
09/2006 - 01/2001
3Carcinoma (Carcinomatosis)
10/2001 - 06/2000
3Melanoma (Melanoma, Malignant)
10/2001 - 06/2000
3Leukemia
06/2001 - 02/2000
3Vascular Remodeling
03/2001 - 02/2001
2Cytopenia
01/2022 - 01/2007
2Sensorineural Hearing Loss
06/2021 - 10/2000
2Diarrhea
01/2020 - 04/2000
2Osteoarthritis
01/2019 - 02/2014
2Osteoporosis
12/2018 - 04/2001
2Schizophrenia (Dementia Praecox)
01/2017 - 01/2017
2Autism Spectrum Disorder
01/2017 - 01/2017
2Neuralgia (Stump Neuralgia)
05/2016 - 03/2015
2Traumatic Brain Injuries (Traumatic Brain Injury)
02/2015 - 03/2011
2Esophageal Neoplasms (Esophageal Cancer)
02/2014 - 03/2000

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
12/2013 - 03/2000
11Prealbumin (Transthyretin)IBA
02/2012 - 02/2000
9Amyloid (Amyloid Fibrils)IBA
06/2011 - 04/2000
7CytokinesIBA
02/2011 - 03/2000
6Glucose (Dextrose)FDA LinkGeneric
01/2020 - 07/2000
6Messenger RNA (mRNA)IBA
01/2014 - 02/2000
5Hormones (Hormone)IBA
01/2022 - 11/2001
5Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2000
5Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2010 - 02/2000
5DNA (Deoxyribonucleic Acid)IBA
02/2007 - 07/2001
4Codon (Codons)IBA
01/2016 - 03/2001
4RNA (Ribonucleic Acid)IBA
11/2014 - 02/2000
4Matrix Metalloproteinases (MMPs)IBA
09/2012 - 08/2000
4InterleukinsIBA
02/2011 - 08/2000
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 01/2001
4EnzymesIBA
06/2009 - 01/2001
4Biological ProductsIBA
01/2006 - 04/2000
3Fulvestrant (Faslodex)FDA Link
01/2021 - 06/2017
3Cisplatin (Platino)FDA LinkGeneric
12/2019 - 10/2000
3SteroidsIBA
04/2016 - 09/2001
3Transcription Factors (Transcription Factor)IBA
04/2015 - 03/2001
3Pharmaceutical PreparationsIBA
01/2014 - 10/2009
3Tissue Plasminogen Activator (Alteplase)FDA Link
09/2012 - 11/2000
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2011 - 06/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 02/2001
3ImmunosorbentsIBA
06/2009 - 11/2001
3AntigensIBA
04/2002 - 06/2000
3Interleukin-4 (Interleukin 4)IBA
12/2001 - 03/2000
3Peptides (Polypeptides)IBA
11/2001 - 06/2000
3NF-kappa B (NF-kB)IBA
10/2001 - 07/2000
3Fluorouracil (Carac)FDA LinkGeneric
03/2001 - 07/2000
2Epidermal Growth Factor (EGF)IBA
01/2022 - 01/2021
2AlpelisibIBA
01/2021 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
01/2020 - 12/2013
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 12/2009
2GangliosidesIBA
01/2019 - 02/2014
2Blood Glucose (Blood Sugar)IBA
08/2017 - 02/2015
2rho-Associated KinasesIBA
01/2017 - 01/2004
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2015 - 01/2005
2Oxygen (Dioxygen)IBA
02/2015 - 05/2006
2Indicators and Reagents (Reagents)IBA
01/2014 - 01/2001

Therapy/Procedure

19Therapeutics
01/2022 - 01/2000
7Radiotherapy
11/2017 - 03/2000
7Transplantation
07/2011 - 06/2004
6Liver Transplantation
02/2012 - 04/2000
5Lasers (Laser)
01/2005 - 11/2000
4Hematopoietic Stem Cell Transplantation
01/2017 - 06/2004
3Drug Therapy (Chemotherapy)
06/2017 - 02/2000
3Hip Replacement Arthroplasty (Total Hip Replacement)
09/2009 - 03/2006
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2001 - 10/2000
2Stem Cell Transplantation
08/2017 - 06/2000